Cargando…

IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate

Naive B cells co-express two BCR isotypes, IgM and IgD, with identical antigen-binding domains but distinct constant regions. IgM but not IgD is downregulated on autoreactive B cells. Because these isotypes are presumed to be redundant, it is unknown how this could impose tolerance. We introduced th...

Descripción completa

Detalles Bibliográficos
Autores principales: Noviski, Mark, Mueller, James L, Satterthwaite, Anne, Garrett-Sinha, Lee Ann, Brombacher, Frank, Zikherman, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897097/
https://www.ncbi.nlm.nih.gov/pubmed/29521626
http://dx.doi.org/10.7554/eLife.35074
_version_ 1783313914495238144
author Noviski, Mark
Mueller, James L
Satterthwaite, Anne
Garrett-Sinha, Lee Ann
Brombacher, Frank
Zikherman, Julie
author_facet Noviski, Mark
Mueller, James L
Satterthwaite, Anne
Garrett-Sinha, Lee Ann
Brombacher, Frank
Zikherman, Julie
author_sort Noviski, Mark
collection PubMed
description Naive B cells co-express two BCR isotypes, IgM and IgD, with identical antigen-binding domains but distinct constant regions. IgM but not IgD is downregulated on autoreactive B cells. Because these isotypes are presumed to be redundant, it is unknown how this could impose tolerance. We introduced the Nur77-eGFP reporter of BCR signaling into mice that express each BCR isotype alone. Despite signaling strongly in vitro, IgD is less sensitive than IgM to endogenous antigen in vivo and developmental fate decisions are skewed accordingly. IgD-only Lyn(−/−) B cells cannot generate autoantibodies and short-lived plasma cells (SLPCs) in vivo, a fate thought to be driven by intense BCR signaling induced by endogenous antigens. Similarly, IgD-only B cells generate normal germinal center, but impaired IgG1(+) SLPC responses to T-dependent immunization. We propose a role for IgD in maintaining the quiescence of autoreactive B cells and restricting their differentiation into autoantibody secreting cells.
format Online
Article
Text
id pubmed-5897097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-58970972018-04-16 IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate Noviski, Mark Mueller, James L Satterthwaite, Anne Garrett-Sinha, Lee Ann Brombacher, Frank Zikherman, Julie eLife Immunology and Inflammation Naive B cells co-express two BCR isotypes, IgM and IgD, with identical antigen-binding domains but distinct constant regions. IgM but not IgD is downregulated on autoreactive B cells. Because these isotypes are presumed to be redundant, it is unknown how this could impose tolerance. We introduced the Nur77-eGFP reporter of BCR signaling into mice that express each BCR isotype alone. Despite signaling strongly in vitro, IgD is less sensitive than IgM to endogenous antigen in vivo and developmental fate decisions are skewed accordingly. IgD-only Lyn(−/−) B cells cannot generate autoantibodies and short-lived plasma cells (SLPCs) in vivo, a fate thought to be driven by intense BCR signaling induced by endogenous antigens. Similarly, IgD-only B cells generate normal germinal center, but impaired IgG1(+) SLPC responses to T-dependent immunization. We propose a role for IgD in maintaining the quiescence of autoreactive B cells and restricting their differentiation into autoantibody secreting cells. eLife Sciences Publications, Ltd 2018-03-09 /pmc/articles/PMC5897097/ /pubmed/29521626 http://dx.doi.org/10.7554/eLife.35074 Text en © 2018, Noviski et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Immunology and Inflammation
Noviski, Mark
Mueller, James L
Satterthwaite, Anne
Garrett-Sinha, Lee Ann
Brombacher, Frank
Zikherman, Julie
IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title_full IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title_fullStr IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title_full_unstemmed IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title_short IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate
title_sort igm and igd b cell receptors differentially respond to endogenous antigens and control b cell fate
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897097/
https://www.ncbi.nlm.nih.gov/pubmed/29521626
http://dx.doi.org/10.7554/eLife.35074
work_keys_str_mv AT noviskimark igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate
AT muellerjamesl igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate
AT satterthwaiteanne igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate
AT garrettsinhaleeann igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate
AT brombacherfrank igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate
AT zikhermanjulie igmandigdbcellreceptorsdifferentiallyrespondtoendogenousantigensandcontrolbcellfate